Development and Validation of a Fast, Semi-Automated Hybrid Imaging Platform to Assess Coronary Atherosclerotic Plaque Morphology, Endothelial Shear Stress and Arterial Inflammation: A Proof of Principle Study (VALID-PET-CT)
VALID-PET-CT
1 other identifier
observational
7
1 country
1
Brief Summary
Imaging the inside of coronary arteries (intravascular imaging) offers great insight into the assessment and treatment of coronary artery disease. Over time, substances such as fat, cholesterol and calcium can build up into 'plaques' in the arteries, causing narrowings or even blockages. These plaques can also rupture, causing cardiovascular events such as heart attacks or strokes. By using ultrasound and infrared technology, intravascular imaging can help assess these plaques, however this is an invasive technique involving angiography. Plaque composition, structure and stability can be affected by inflammation and the stress that the arteries are under. The investigators have pioneered novel minimally-invasive methods for modelling arterial stress using computed tomography coronary angiography (CTCA), as well as imaging coronary arterial inflammation using a positron emission tomography (PET) scan. Before embarking upon a large-scale clinical outcome study to determine whether these novel methods can improve risk prediction, the aim is to perform a proof-of-principle study to further develop our methodology for hybrid image analysis, and to validate this technique against high-resolution intravascular imaging as a surrogate marker of histology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2019
CompletedFirst Posted
Study publicly available on registry
December 19, 2019
CompletedStudy Start
First participant enrolled
November 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2023
CompletedFebruary 6, 2025
February 1, 2025
2.9 years
December 13, 2019
February 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Faesibility of co-registration of CTCA and PET-CT data
All studied vessels will be dividen into 3 mm segments and the CTCA and PET-CT studies will be co-registered electronically. The faesibility of this will be reported
12 months
Secondary Outcomes (4)
Comparing PET-CT, CTCA and intravascular imaging: plaque volume
12 months
Comparing PET-CT, CTCA and intravascular imaging: plaque composition
12 months
Comparing PET-CT, CTCA and intravascular imaging: haemodynamic forces
12 months
Comparing PET-CT, CTCA and intravascular imaging: presence of inflammation
12 months
Interventions
PET-CT compared to intravascular imaging for assessment of atherosclerotic plaques in stable angina patients
Eligibility Criteria
Stable angina patients with known coronary artery disease referred for further invasive assessment as part of routine clincal care
You may qualify if:
- Age ≥40
- Stable angina, defined as typical symptoms with evidence of reversible ischemia in non-invasive test and/or documented obstructive coronary artery disease on coronary angiography
- Patient that is willing and can provide written informed consent.
You may not qualify if:
- Acute coronary syndrome within \<3 months
- Pregnancy
- Estimated glomerular filtration rate (eGFR) \<60ml/min/1.73m²
- Previous bypass surgery
- Decompensated heart failure, or left ventricular ejection fraction less than 30%
- Patient allergic to contrast or cannot receive treatment with aspirin, heparin, or thienopyridines
- Anticipated life expectancy \<2 years
- Flow limiting coronary artery disease in the proximal segments of all the 3 epicardial coronaries
- History of heart transplantation
- Patient that requires surgical revascularization
- Extensive coronary artery disease (i.e., multiple chronic total occlusions) or tortuous coronary anatomy that does not allow assessment of the
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St Bartholomew's Hospital
London, EC1A 7BE, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2019
First Posted
December 19, 2019
Study Start
November 1, 2020
Primary Completion
October 10, 2023
Study Completion
October 10, 2023
Last Updated
February 6, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share